1
|
Boddaert N, Salvador A, Chandesris MO, Lemaître H, Grévent D, Gauthier C, Naggara O, Georgin-Lavialle S, Moura DS, Munsch F, Jaafari N, Zilbovicius M, Lortholary O, Gaillard R, Hermine O. Neuroimaging evidence of brain abnormalities in mastocytosis. Transl Psychiatry 2017; 7:e1197. [PMID: 28786975 PMCID: PMC5611717 DOI: 10.1038/tp.2017.137] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/21/2016] [Revised: 04/06/2017] [Accepted: 04/20/2017] [Indexed: 01/08/2023] Open
Abstract
Mastocytosis is a rare disease in which chronic symptoms are related to mast cell accumulation and activation. Patients can display depression-anxiety-like symptoms and cognitive impairment. The pathophysiology of these symptoms may be associated with tissular mast cell infiltration, mast cell mediator release or both. The objective of this study is to perform morphological or functional brain analyses in mastocytosis to identify brain changes associated with this mast cell disorder. We performed a prospective and monocentric comparative study to evaluate the link between subjective psycho-cognitive complaints, psychiatric evaluation and objective medical data using magnetic resonance imaging with morphological and perfusion sequences (arterial spin-labeled perfusion) in 39 patients with mastocytosis compared with 33 healthy controls. In the test cohort of 39 mastocytosis patients with psycho-cognitive complaints, we found that 49% of them had morphological brain abnormalities, mainly abnormal punctuated white matter abnormalities (WMA). WMA were equally frequent in cutaneous mastocytosis patients and indolent forms of systemic mastocytosis patients (42% and 41% of patients with WMA, respectively). Patients with WMA showed increased perfusion in the putamen compared with patients without WMA and with healthy controls. Putamen perfusion was also negatively correlated with depression subscores. This study demonstrates, for we believe the first time, a high prevalence of morphological and functional abnormalities in the brains of mastocytosis patients with neuropsychiatric complaints. Further studies are required to determine the mechanism underpinning this association and to ascertain its specificity.
Collapse
Affiliation(s)
- N Boddaert
- Department of Pediatric Radiology, Hôpital Necker-Enfants Malades, AP-HP, University René Descartes, PRES Sorbonne Paris Cité, INSERM U1000 and UMR 1163, Institut Imagine, Paris, France,Department of Pediatric Radiology, Hôpital Necker-Enfants Malades, AP-HP, University René Descartes, PRES Sorbonne Paris Cité, INSERM U1000 and UMR 1163, Institut Imagine, 149 rue de Sèvres, 75015 Paris, France. E-mail:
| | - A Salvador
- Laboratoire de “Physiopathologie des Maladies Psychiatriques”, Centre de Psychiatrie et Neurosciences U894, INSERM, Université Paris Descartes, Sorbonne Paris Cité, Paris, France,Service de Psychiatrie, Centre Hospitalier Sainte-Anne, Université Paris Descartes, Sorbonne Paris Cité, Faculté de Médecine Paris Descartes, Paris, France
| | - M O Chandesris
- Centre de Référence des Mastocytoses, Université Paris Descartes, Sorbonne, Paris Cité, Hôpital Necker-Enfants Malades, Fondation Imagine, Paris, France,Service d'Hématologie Adulte, Université Paris Descartes, Sorbonne, Paris Cité, Assistance Publique-Hôpitaux de Paris, Institut Imagine, Hôpital Necker-Enfants Malades, Paris, France
| | - H Lemaître
- Department of Pediatric Radiology, Hôpital Necker-Enfants Malades, AP-HP, University René Descartes, PRES Sorbonne Paris Cité, INSERM U1000 and UMR 1163, Institut Imagine, Paris, France
| | - D Grévent
- Department of Pediatric Radiology, Hôpital Necker-Enfants Malades, AP-HP, University René Descartes, PRES Sorbonne Paris Cité, INSERM U1000 and UMR 1163, Institut Imagine, Paris, France
| | - C Gauthier
- Service de Psychiatrie, Centre Hospitalier Sainte-Anne, Université Paris Descartes, Sorbonne Paris Cité, Faculté de Médecine Paris Descartes, Paris, France
| | - O Naggara
- Department of Neuroradiology, Service Hospitalo-Universitaire, Centre Hospitalier Sainte-Anne, Université Paris Descartes, Sorbonne Paris Cité, INSERM UMR894, Paris, France
| | - S Georgin-Lavialle
- Centre de Référence des Mastocytoses, Université Paris Descartes, Sorbonne, Paris Cité, Hôpital Necker-Enfants Malades, Fondation Imagine, Paris, France,INSERM U1163 and CNRS ERL 8254 and Laboratory of Physiopathology and Treatment of Hematological Disorders, Hôpital Necker-Enfants Malades, Paris, France,Service de Médecine Interne, Hôpital Tenon, Université Pierre et Marie Curie, Assistance Publique-Hôpitaux de Paris, Paris, France
| | - D S Moura
- Centre de Référence des Mastocytoses, Université Paris Descartes, Sorbonne, Paris Cité, Hôpital Necker-Enfants Malades, Fondation Imagine, Paris, France,INSERM U1163 and CNRS ERL 8254 and Laboratory of Physiopathology and Treatment of Hematological Disorders, Hôpital Necker-Enfants Malades, Paris, France,Laboratoire de Psychopathologie et Processus de Santé, EA 4057, IUPDP, Institut de Psychologie, Université Paris Descartes, Paris, France
| | - F Munsch
- MRI France GE Healthcare, Vélizy Villacoublay, France and Université de Bordeaux, Bordeaux, France,Inserm U1215 - Neurocentre Magendie, Bordeaux, France
| | - N Jaafari
- Unité de Recherche Clinique Intersectorielle en Psychiatrie à Vocation Régionale Pierre Deniker du Centre Hospitalier Henri Laborit, INSERM CIC-P 1402, INSERM U 1084 Laboratoire Expérimental et Clinique en Neurosciences, Univ Poitiers, CHU Poitiers, Groupement De Recherche CNRS 3557, Poitiers, France
| | - M Zilbovicius
- Department of Pediatric Radiology, Hôpital Necker-Enfants Malades, AP-HP, University René Descartes, PRES Sorbonne Paris Cité, INSERM U1000 and UMR 1163, Institut Imagine, Paris, France
| | - O Lortholary
- Centre de Référence des Mastocytoses, Université Paris Descartes, Sorbonne, Paris Cité, Hôpital Necker-Enfants Malades, Fondation Imagine, Paris, France,Infectious Diseases Unit, Necker-Enfants Malades Hospital, AP-HP Paris, Paris, France,Paris Descartes University, Imagine Institute, Paris, France
| | - R Gaillard
- Laboratoire de “Physiopathologie des Maladies Psychiatriques”, Centre de Psychiatrie et Neurosciences U894, INSERM, Université Paris Descartes, Sorbonne Paris Cité, Paris, France,Service de Psychiatrie, Centre Hospitalier Sainte-Anne, Université Paris Descartes, Sorbonne Paris Cité, Faculté de Médecine Paris Descartes, Paris, France,Centre de Référence des Mastocytoses, Université Paris Descartes, Sorbonne, Paris Cité, Hôpital Necker-Enfants Malades, Fondation Imagine, Paris, France,Human Histopathology and Animal Models, Infection and Epidemiology Department, Institut Pasteur, Paris, France
| | - O Hermine
- Centre de Référence des Mastocytoses, Université Paris Descartes, Sorbonne, Paris Cité, Hôpital Necker-Enfants Malades, Fondation Imagine, Paris, France,Service d'Hématologie Adulte, Université Paris Descartes, Sorbonne, Paris Cité, Assistance Publique-Hôpitaux de Paris, Institut Imagine, Hôpital Necker-Enfants Malades, Paris, France,INSERM U1163 and CNRS ERL 8254 and Laboratory of Physiopathology and Treatment of Hematological Disorders, Hôpital Necker-Enfants Malades, Paris, France
| |
Collapse
|
2
|
Rodrigues F, Georgin-Lavialle S, Chandesris M, Barète S, Bouktit H, Dubreuil P, Hamidou M, Saadoun D, Gaillard R, Hermine O. Maladies neuro-inflammatoires associées à la mastocytose : série de 8 cas. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.10.116] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
3
|
Lortholary O, Chandesris MO, Bulai Livideanu C, Paul C, Guillet G, Jassem E, Niedoszytko M, Barete S, Verstovsek S, Damaj G, Canioni D, Fraitag S, Lhermitte L, Georgin-Lavialle S, Afrin L, Hanssens K, Agopian J, Kinet JP, Auclair C, Mansfield C, Moussy A, Dubreuil P, Hermine O. Masitinib dans le traitement de la mastocytose systemique sévère de forme indolente ou latente : un essai clinique de phase 3 randomisé et controllé. Ann Dermatol Venereol 2016. [DOI: 10.1016/j.annder.2016.09.227] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
4
|
Georgin-Lavialle S, Launay JM, Côté F, Soucié E, Soria A, Damaj G, Moura DS, Canioni D, Hanssens K, Chandesris MO, Barète S, Dubreuil P, Lortholary O, Hermine O, Sokol H. Decreased tryptophan and increased kynurenine levels in mastocytosis associated with digestive symptoms. Allergy 2016; 71:416-20. [PMID: 26841279 DOI: 10.1111/all.12802] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/25/2015] [Indexed: 12/23/2022]
Abstract
The main metabolism pathway of tryptophan is protein formation, but it can also be metabolized into serotonin and kynurenine. Indoleamine 2,3-dioxygenase (IDO) is the enzyme that catalyzes the degradation of tryptophan into kynurenine. Mastocytosis is a heterogeneous disease characterized by mast cell accumulation in various tissues with 57% of patients having gastrointestinal involvement. We studied tryptophan metabolism in mastocytosis patients displaying or not gastrointestinal features and healthy subjects (n = 26 in each group). Mastocytosis patients with digestive symptoms displayed significantly increased kynurenine level and IDO activity as compared to healthy controls and mastocytosis patients without digestive symptoms. This could be linked to mast cell-mediated digestive inflammation among patients with mastocytosis. This work is the first focusing on kynurenine pathway in a mast cell disease and could help to understand the pathogenesis of digestive features in mastocytosis as well as in other mast cell-mediated diseases.
Collapse
Affiliation(s)
- S. Georgin-Lavialle
- Service de Médecine Interne; Hôpital Tenon; Assistance Publique-Hôpitaux de Paris; Université Pierre et Marie Curie-Paris 6; Paris France
- Centre de Référence des Mastocytoses; Sorbonne, Paris Cité; Hôpital Necker Enfants malades; Institut Imagine; Université Paris Descartes; Paris France
| | - J.-M. Launay
- Laboratoire de Biochimie et Biologie Moléculaire; Hôpital Lariboisière; Assistance Publique-Hôpitaux de Paris; INSERM U942; RTRS Santé Mentale; Paris France
| | - F. Côté
- INSERM U1163 and CNRS ERL 8254 and Laboratory of Physiopathology and Treatment of Hematological Disorders Hôpital Necker-Enfants malades; Institut Imagine; Paris Cedex 15 France
| | - E. Soucié
- INSERM UMR 891; Centre de Recherche en Cancérologie de Marseille; Laboratoire d'Hématopoïèse Moléculaire et Fonctionnelle; Marseille France
| | - A. Soria
- Centre de Référence des Mastocytoses; Sorbonne, Paris Cité; Hôpital Necker Enfants malades; Institut Imagine; Université Paris Descartes; Paris France
| | - G. Damaj
- Centre de Référence des Mastocytoses; Sorbonne, Paris Cité; Hôpital Necker Enfants malades; Institut Imagine; Université Paris Descartes; Paris France
- Hématologie; Faculté de Médecine; Centre Hospitalier Universitaire; Caen France
| | - D. S. Moura
- Centre de Référence des Mastocytoses; Sorbonne, Paris Cité; Hôpital Necker Enfants malades; Institut Imagine; Université Paris Descartes; Paris France
| | - D. Canioni
- Centre de Référence des Mastocytoses; Sorbonne, Paris Cité; Hôpital Necker Enfants malades; Institut Imagine; Université Paris Descartes; Paris France
- Service d'Anatomie-Pathologique; Hôpital Necker-Enfants Malades; Assistance Publique-Hôpitaux de Paris; Université Paris Descartes; Paris France
| | - K. Hanssens
- INSERM UMR 891; Centre de Recherche en Cancérologie de Marseille; Laboratoire d'Hématopoïèse Moléculaire et Fonctionnelle; Marseille France
| | - M.-O. Chandesris
- Centre de Référence des Mastocytoses; Sorbonne, Paris Cité; Hôpital Necker Enfants malades; Institut Imagine; Université Paris Descartes; Paris France
- Service d'hématologie Adulte; Sorbonne, Paris Cité; Assistance Publique-Hôpitaux de Paris; Institut Imagine; Hôpital Necker-Enfants Malades; Université Paris Descartes; Paris France
| | - S. Barète
- Centre de Référence des Mastocytoses; Sorbonne, Paris Cité; Hôpital Necker Enfants malades; Institut Imagine; Université Paris Descartes; Paris France
| | - P. Dubreuil
- Centre de Référence des Mastocytoses; Sorbonne, Paris Cité; Hôpital Necker Enfants malades; Institut Imagine; Université Paris Descartes; Paris France
- INSERM UMR 891; Centre de Recherche en Cancérologie de Marseille; Laboratoire d'Hématopoïèse Moléculaire et Fonctionnelle; Marseille France
| | - O. Lortholary
- Centre de Référence des Mastocytoses; Sorbonne, Paris Cité; Hôpital Necker Enfants malades; Institut Imagine; Université Paris Descartes; Paris France
- Sorbonne, Paris Cité; Service des Maladies Infectieuses et Tropicales; Assistance Publique-Hôpitaux de Paris; Hôpital Necker-Enfants Malades; IHU Imagine; Université Paris Descartes; Paris France
| | - O. Hermine
- Centre de Référence des Mastocytoses; Sorbonne, Paris Cité; Hôpital Necker Enfants malades; Institut Imagine; Université Paris Descartes; Paris France
- Service d'hématologie Adulte; Sorbonne, Paris Cité; Assistance Publique-Hôpitaux de Paris; Institut Imagine; Hôpital Necker-Enfants Malades; Université Paris Descartes; Paris France
| | - H. Sokol
- Service de Gastroentérologie et Nutrition; Hôpital Saint-Antoine; AP-HP; Université Pierre et Marie Curie-Paris 6; Paris France
- Equipe AVENIR; Laboratoire INSERM U1157/UMR CNRS 7203; Université Pierre et Marie Curie 6; Paris France
- Equipe Interactions des Bactéries Commensales et Probiotiques Avec l'hôte; INRA; MICALIS; Jouy en Josas France
| |
Collapse
|
5
|
Monnier J, Georgin-Lavialle S, Canioni D, Soussan M, Lhermitte L, Bruneau J, Dubreuil P, Chandesris MO, Bodemer C, Gandhi D, Hermine O. Sarcomes mastocytaires : série de cas français et revue de la littérature. Ann Dermatol Venereol 2015. [DOI: 10.1016/j.annder.2015.10.063] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
6
|
Djelbani-Ahmed S, Chandesris MO, Mekinian A, Canioni D, Brouzes C, Hanssens K, Pop G, Durieu I, Durupt S, Grosbois B, Besnard S, Tournilhac O, Beyne-Rauzy O, Agapé P, Delmer A, Ranta D, Jeandel PY, Georgin-Lavialle S, Frenzel L, Damaj G, Eder V, Lortholary O, Hermine O, Fain O, Soussan M. FDG-PET/CT findings in systemic mastocytosis: a French multicentre study. Eur J Nucl Med Mol Imaging 2015; 42:2013-20. [PMID: 26140850 DOI: 10.1007/s00259-015-3117-3] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2015] [Accepted: 06/10/2015] [Indexed: 12/24/2022]
Abstract
INTRODUCTION Mastocytosis is a clonal haematological disease characterized by uncontrolled proliferation and the activation of mast cells. The value of FDG-PET/CT (FDG-PET) in mastocytosis has yet to be determined. METHODS We retrospectively identified patients with an established diagnosis of systemic mastocytosis (SM), according to the WHO criteria, who underwent PET using the French Reference Centre for Mastocytosis database. Semi-quantitative and visual analysis of FDG-PET was performed and compared to the clinico-biological data. RESULTS Our cohort included 19 adult patients, median age 65 years [range 58-74], including three with smouldering SM (SSM), three with aggressive SM (ASM), 10 with an associated clonal haematological non-mast-cell lineage disease (SM-AHNMD), and three with mast cell sarcoma (MCS). FDG-PET was performed at the time of the SM diagnosis (15/19), to evaluate lymph node (LN) activity (3/19) or the efficacy of therapy (1/19). FDG uptake was observed in the bone marrow (BM) (9/19, 47%), LN (6/19, 32%), spleen (12/19, 63%), or liver (1/19, 5%). No significant FDG uptake was observed in the SSM and ASM patients. A pathological FDG uptake was observed in the BM of 6/10 patients with SM-AHNMD, appearing as diffuse and homogeneous, and in the LN of 5/10 patients. All 3 MCS patients showed intense and multifocal BM pathological uptake, mimicking metastasis. No correlation was found between the FDG-PET findings and serum tryptase levels, BM mast cell infiltration percentage, and CD30 and CD2 expression by mast cells. CONCLUSIONS FDG uptake does not appear to be a sensitive marker of mast cell activation or proliferation because no significant FDG uptake was observed in most common forms of mastocytosis (notably purely aggressive SM). However, pathological FDG uptake was observed in the SM-AHNMD and in MCS cases, suggesting a role of FDG-PET in their early identification and as a tool of therapeutic assessment in this subgroup of patients.
Collapse
Affiliation(s)
- S Djelbani-Ahmed
- Department of Nuclear Medicine, Avicenne Hospital, Assistance Publique - Hôpitaux de Paris (APHP), Bobigny, France
- Sorbonne Paris Cité, Paris 13 University, Bobigny, France
| | - M O Chandesris
- French Reference center for Mastocytosis (Centre de Référence des Mastocytoses, CEREMAST), Necker Children's Hospital, APHP, Paris, France
- Department of Haematology, Necker Children's Hospital, APHP, Paris, France
- Sorbonne Paris Cité, Imagine Institute, Paris Descartes University, Paris, France
| | - A Mekinian
- Department of Internal Medicine and Inflammation-Immunopathology-Biotherapy Department (DHU i2B), AP-HP, Saint Antoine Hospital, Paris, France
| | - D Canioni
- French Reference center for Mastocytosis (Centre de Référence des Mastocytoses, CEREMAST), Necker Children's Hospital, APHP, Paris, France
- Sorbonne Paris Cité, Imagine Institute, Paris Descartes University, Paris, France
- Department of Pathology, Necker Children's Hospital, APHP, Paris, France
| | - C Brouzes
- French Reference center for Mastocytosis (Centre de Référence des Mastocytoses, CEREMAST), Necker Children's Hospital, APHP, Paris, France
- Sorbonne Paris Cité, Imagine Institute, Paris Descartes University, Paris, France
- Laboratory of Haematology, Necker Children's Hospital, APHP, Paris, France
| | - K Hanssens
- French Reference center for Mastocytosis (Centre de Référence des Mastocytoses, CEREMAST), Necker Children's Hospital, APHP, Paris, France
- INSERM U1068, Centre de Recherche en Cancérologie de Marseille (Signaling, Hematopoiesis and Mechanism of Oncogenesis), Paoli Calmettes Institute, Aix-Marseille University, Marseille, France
| | - G Pop
- Department of Nuclear Medicine, Avicenne Hospital, Assistance Publique - Hôpitaux de Paris (APHP), Bobigny, France
| | - I Durieu
- Department of Internal and Vascular Medicine, Hospices Civils de Lyon, Groupe Hopitalier Sud, Université de Lyon, Pierre-Bénite, France
| | - S Durupt
- Department of Internal and Vascular Medicine, Hospices Civils de Lyon, Groupe Hopitalier Sud, Université de Lyon, Pierre-Bénite, France
| | - B Grosbois
- Department of Internal Medicine, Rennes University Hospital, Rennes, France
| | - S Besnard
- Department of Internal Medicine, Rennes University Hospital, Rennes, France
| | - O Tournilhac
- Department of Internal Medicine, Clermont-Ferrand University Hospital, Clermont-Ferrand, France
| | - O Beyne-Rauzy
- Department of Internal Medicine, Purpan University Hospital, Toulouse, France
| | - P Agapé
- Department of Oncology and Haematology, Saint-Denis University Hospital, Saint-Denis de la Réunion, France
| | - A Delmer
- Department of Haematology, Reims University Hospital, Reims, France
| | - D Ranta
- Department of Haematology, Brabois University Hospital, Vandoeuvre les Nancy, France
| | - P Y Jeandel
- Department of Internal Medicine, Nice University Hospital, Nice, France
| | | | - L Frenzel
- French Reference center for Mastocytosis (Centre de Référence des Mastocytoses, CEREMAST), Necker Children's Hospital, APHP, Paris, France
- Department of Haematology, Necker Children's Hospital, APHP, Paris, France
- Sorbonne Paris Cité, Imagine Institute, Paris Descartes University, Paris, France
| | - G Damaj
- French Reference center for Mastocytosis (Centre de Référence des Mastocytoses, CEREMAST), Necker Children's Hospital, APHP, Paris, France
- Department of Haematology, Caen University Hospital, Caen, France
| | - V Eder
- Department of Nuclear Medicine, Avicenne Hospital, Assistance Publique - Hôpitaux de Paris (APHP), Bobigny, France
| | - O Lortholary
- French Reference center for Mastocytosis (Centre de Référence des Mastocytoses, CEREMAST), Necker Children's Hospital, APHP, Paris, France
- Sorbonne Paris Cité, Imagine Institute, Paris Descartes University, Paris, France
- Department of Infectious Diseases and Tropical Medicine, Necker Children's Hospital, APHP, Pasteur Institute, Paris, France
| | - O Hermine
- French Reference center for Mastocytosis (Centre de Référence des Mastocytoses, CEREMAST), Necker Children's Hospital, APHP, Paris, France
- Department of Haematology, Necker Children's Hospital, APHP, Paris, France
- Sorbonne Paris Cité, Imagine Institute, Paris Descartes University, Paris, France
| | - O Fain
- Department of Internal Medicine and Inflammation-Immunopathology-Biotherapy Department (DHU i2B), AP-HP, Saint Antoine Hospital, Paris, France
| | - M Soussan
- Department of Nuclear Medicine, Avicenne Hospital, Assistance Publique - Hôpitaux de Paris (APHP), Bobigny, France.
- Sorbonne Paris Cité, Paris 13 University, Bobigny, France.
| |
Collapse
|
7
|
Gras J, Canioni D, Briot K, Blanchais A, Lortholary O, Hermine O, Chandesris M. Une épidurite compressive et des lésions osseuses multiples révélant une mastocytose inclassable 20ans après une tumeur germinale non séminomateuse du médiastin : une association non fortuite. Rev Med Interne 2014. [DOI: 10.1016/j.revmed.2014.10.338] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
8
|
Rouet A, Damaj G, Aouba A, Chandesris M, Barète S, Fain O, Durieu I, Grosbois B, Beyne-Rauzy O, Lortholary O, Hermine O, Georgin-Lavialle S. Mastocytose du sujet âgé : à propos de 195 patients dont 80 cas français et 115 cas issus de la littérature. Rev Med Interne 2013. [DOI: 10.1016/j.revmed.2013.10.098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
9
|
Fagedet D, Jacquier JP, Chandesris MO, Deroux A, Boccon-Gibod I, Sarrot-Reynauld F, Bouillet L. Mastocytose et allergie aux hyménoptères, une association à ne pas méconnaître ! Rev Med Interne 2013. [DOI: 10.1016/j.revmed.2013.03.163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
10
|
Georgin-Lavialle S, Lhermitte L, Chandesris M, Hermine O, Damaj G. La leucémie à mastocytes : description des principales caractéristiques clinico-biologiques et évolutives à partir de 51 cas : les 47 cas publiés dans la littérature internationale et quatre cas français. Rev Med Interne 2012. [DOI: 10.1016/j.revmed.2012.10.051] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
11
|
Bulai Livideanu C, Tournier E, Laurent C, Sans B, Laroche M, Lamant L, Chandesris MO, Barete S, Hermine O, Laurent G, Paul C. Évaluation de l’atteinte cutanée mastocytaire sous Interféron alpha. Ann Dermatol Venereol 2012. [DOI: 10.1016/j.annder.2012.10.524] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
12
|
Lafont E, Lhermitte L, Chandesris M, Hirsch I, Guichard I, Durieu I, Rétornaz F, Hamidou M, Barete S, Lortholary O, Hermine O, Georgin-Lavialle S. Flushs sans urticaire pigmentaire au cours de la mastocytose systémique : étude de 9 cas. Rev Med Interne 2012. [DOI: 10.1016/j.revmed.2012.10.083] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
13
|
Canioni D, Lhermitte L, Georgin-Lavialle S, Chandesris MO, Asnafi V, Lortholary O, Hermine O. L’absence d’expression du CD2 sur les mastocytes médullaires détermine un nouveau sous-type nosologique de mastocytose agressive : étude d’une cohorte de 85 patients. Ann Pathol 2012. [DOI: 10.1016/j.annpat.2012.09.167] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
14
|
Silva-Moura D, Georgin-Lavialle S, Sultan S, Barete S, Chandesris MO, Lortholary O, Gaillard R, Hermine O. Troubles cognitifs au cours de la mastocytose : étude de la prévalence, des caractéristiques chez 57 patients. Rev Med Interne 2012. [DOI: 10.1016/j.revmed.2012.03.096] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
15
|
Georgin-Lavialle S, Chandesris MO, Lhermitte L, Guichard I, Durieu I, de Gennes C, Lavigne C, Guilpain P, Fontaine C, Barete S, Lortholary O, Hermine O. Chocs anaphylactiques et mastocytose systémique : étude de 11 cas. Rev Med Interne 2012. [DOI: 10.1016/j.revmed.2012.03.095] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
16
|
Georgin-Lavialle S, Lhermitte L, Canioni D, Chandesris MO, Barete S, Durieu I, Guichard I, Fain O, Hamidou M, Sarrot-Reynauld F, Lortholary O, Hermine O. Nouvelle entité au sein de la mastocytose avec très mauvais pronostic et associée à la négativité du CD2 sur les mastocytes médullaires : étude d’une cohorte de 85 patients. Rev Med Interne 2012. [DOI: 10.1016/j.revmed.2012.03.097] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
17
|
Brun M, Chandesris MO, Mazodier K, Chiche L, Ebbo M, Legall S, Veit V, Bernit E, Durand JM, Harle JR, Nicolino-Brunet C, Kaplanski G. Déficit spécifique de l’expression érythrocytaire de la molécule régulatrice du complément CD59 au cours des anémies hémolytiques par agglutinines froides. Rev Med Interne 2011. [DOI: 10.1016/j.revmed.2011.10.379] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/15/2022]
|
18
|
Chandesris M, Azarine A, Ong K, Taleb S, Boutouyrie P, Mousseaux E, Clément O, Picard C, Mallat Z, Fischer A. P5.02 FREQUENT AND WIDESPREAD VASCULAR ABNORMALITIES IN HUMAN STAT3 DEFICIENCY. Artery Res 2011. [DOI: 10.1016/j.artres.2011.10.059] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/15/2022] Open
|
19
|
Lanternier F, Boutboul D, Menotti J, Chandesris MO, Sarfati C, Mamzer Bruneel MF, Calmus Y, Mechaï F, Viard JP, Lecuit M, Bougnoux ME, Lortholary O. Microsporidiosis in solid organ transplant recipients: two Enterocytozoon bieneusi cases and review. Transpl Infect Dis 2008; 11:83-8. [PMID: 18803616 DOI: 10.1111/j.1399-3062.2008.00347.x] [Citation(s) in RCA: 80] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
Microsporidiosis first came to prominence as an opportunistic infection in patients with acquired immunodeficiency syndrome. Microsporidia are now emerging pathogens responsible for severe diarrhea during solid organ transplantation. Two main clinical entities can be identified: infection by Enterocytozoon bieneusi, causing diarrhea with limited treatment options; and infection by Encephalitozoon intestinalis, which may disseminate and usually responds to albendazole treatment. We describe here 2 cases of microsporidiosis caused by E. bieneusi in a renal and a liver transplant recipient, respectively, in whom complete clinical efficacy of a short course of fumagillin therapy was obtained. Long-term microbiological eradication was assessed using classical methods and monitored using a real-time quantitative polymerase chain reaction-based method. Both patients experienced drug-induced thrombocytopenia, which resolved after withdrawal of the treatment. We also review the 18 other previously reported cases of microsporidiosis in transplant recipients. In case of persistent diarrhea in solid organ transplant patients, microsporidiosis should be considered. Based on the present experience, treating E. bieneusi infection with 7 days of fumagillin therapy is adequate to eradicate E. bieneusi in this context.
Collapse
Affiliation(s)
- F Lanternier
- Centre d'Infectiologie Necker-Pasteur, Service des Maladies Infectieuses et Tropicales, Hôpital Necker-Enfants malades, Université Paris Descartes, Paris, France
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
20
|
Parize P, Chandesris M, Mimoun M, Anglicheau D, Bienvenu B, Viard JP, Guillevin L, Herman P, Lecuit M, Lortholary O. Otite maligne externe aspergillaire traitée par voriconazole : à propos de deux cas. Rev Med Interne 2008. [DOI: 10.1016/j.revmed.2008.03.202] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
21
|
Schmulewitz L, Chandesris MO, Mainardi JL, Poirée S, Viard JP, Lecuit M, Mamzer-Bruneel MF, Lortholary O. Invasive Pasteurella multocida sinusitis in a renal transplant patient. Transpl Infect Dis 2008; 10:206-8. [PMID: 17655653 DOI: 10.1111/j.1399-3062.2007.00270.x] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Pasteurella are commensal gram-negative bacteria isolated from the oral cavity of many domesticated animals. Most human infections occur post animal bite or scratch injury resulting in local cutaneous infection; however, case reports suggest that transmission may occur via animal secretions. Pasteurella species can be associated with serious systemic infections particularly in those with underlying disease and in the immunocompromised. We present a case of invasive Pasteurella multocida sinusitis in an immunocompromised renal transplant patient most likely acquired from a pet dog through direct mucosal inoculation via licking.
Collapse
Affiliation(s)
- L Schmulewitz
- Service des Maladies Infectieuses et Tropicales, Centre d'Infectiologie Necker-Pasteur, Hôpital Necker-Enfants Malades, Université Paris V, René Descartes, Paris, France
| | | | | | | | | | | | | | | |
Collapse
|
22
|
Schmulewitz L, Lortholary O, Mainardi J, Poiree S, Viard J, Lecuit M, Chandesris M, Mamzer-Bruneel M. A question of congestion. J Infect 2008. [DOI: 10.1016/j.jinf.2008.01.039] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
23
|
Chandesris MO, Soulier J, Labaume S, Crinquette A, Repellini L, Chemin K, Malphettes M, Fieschi C, Asli B, Uzunhan Y, Fermand JP, Bories JC, Arnulf B. Detection and follow-up of fibroblast growth factor receptor 3 expression on bone marrow and circulating plasma cells by flow cytometry in patients with t(4;14) multiple myeloma. Br J Haematol 2007; 136:609-14. [PMID: 17223917 DOI: 10.1111/j.1365-2141.2006.06479.x] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Abstract
The t(4;14)(p16;q32) translocation, found in 15% of multiple myeloma (MM) cases, indicates a poor prognosis. Plasma cells (PC) with t(4;14) ectopically express the fibroblast growth factor receptor 3 (FGFR3) tyrosine kinase receptor, which has potential transforming activity and may represent a therapeutic target. To detect FGFR3 protein expression, bone marrow (BM) aspirate from 200 consecutive newly diagnosed (n = 116) or relapsing (n = 74) MM patients was studied by flow cytometry (FC) using anti-CD138 and anti-FGFR3 antibodies. FC data was compared to real time quantitative-polymerase chain reaction (RQ-PCR) of the IGH-MMSET and FGFR3 transcripts. An IGH-MMSET transcript was found in 24/200 patients (12%). In 20 of these, FC detected CD138(+)/FGFR3(+) cells. No expression of FGFR3 was detected in the 4 FGFR3(-) cases by RQ-PCR. FGFR3 was never expressed on PC without t(4;14). Circulating PC (CPC) were detected in patients with (11/11) and patients without (13/41) t(4;14). In 2/8 t(4;14) cases studied longitudinally, coexisting FGFR3(+) and FGFR3(-) CPC were observed. Fluorescent in situ hybridisation (FISH) analysis of the FGFR3(-) subclones showed deletion of the der(14) in one patient. In conclusion, as a supplemental method to RQ-PCR or FISH, FC analysis of FGFR3 expression is a reliable and routinely available method for the detection and management of new therapeutic approaches of t(4;14) MM.
Collapse
MESH Headings
- Biomarkers, Tumor/blood
- Biomarkers, Tumor/metabolism
- Bone Marrow Cells/metabolism
- Chromosomes, Human, Pair 14/genetics
- Chromosomes, Human, Pair 4/genetics
- Female
- Flow Cytometry/methods
- Follow-Up Studies
- Humans
- Male
- Middle Aged
- Multiple Myeloma/genetics
- Multiple Myeloma/metabolism
- Multiple Myeloma/therapy
- Neoplasm Proteins/blood
- Neoplasm Proteins/metabolism
- Plasma Cells/metabolism
- Polymerase Chain Reaction/methods
- Receptor, Fibroblast Growth Factor, Type 3/blood
- Receptor, Fibroblast Growth Factor, Type 3/metabolism
- Translocation, Genetic
- Tumor Cells, Cultured
Collapse
Affiliation(s)
- M O Chandesris
- EA 3963, Paris VII University, Saint-Louis Hospital, AP-HP, Paris, France
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
24
|
Chandesris M, Etienne A, Lemordant P, Gayet S, Bernit E, Veit V, Kaplanski G, Harlé J. L'anémie hémolytique auto-immune (AHAI): une manifestation extrahépatique méconnue de l'hépatite C. Rev Med Interne 2003. [DOI: 10.1016/s0248-8663(03)80404-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
25
|
Chandesris M, Gaye S, Bernit E, Chiaroni J, Veit V, Kapianski G, Harlé J. Agglutinines froides: À propos de 52 cas. Rev Med Interne 2003. [DOI: 10.1016/s0248-8663(03)80049-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
26
|
Chandesris M, Bernit E, Schieinitz N, Nezri M, De Micco C, Henry J, Veit V, Kaplanski G, Harlé J. Une localisation inhabituelle et dramatique de périartérite noueuse liée au VHC. Rev Med Interne 2002. [DOI: 10.1016/s0248-8663(02)80205-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
27
|
Chandesris M, Tundidor C, Crebassa C, Schleinitz N, Veit V, Kaplanski G, Harlé J. Abcès profond et mauvais état dentaire : penser à Fusobacterium nucleatum. Rev Med Interne 2001. [DOI: 10.1016/s0248-8663(01)83605-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|